Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Bismuth Potassium Citrate,Metronidazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : AbbVie Inc
Deal Size : Undisclosed
Deal Type : Acquisition
Details : Pylera®, a 3-in-1 combination of antimicrobial products, is indicated for the treatment of patients with Helicobacter pylori infection suffering from gastro-duodenal ulcer disease.
Product Name : Pylera
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
May 07, 2022
Lead Product(s) : Bismuth Potassium Citrate,Metronidazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : AbbVie Inc
Deal Size : Undisclosed
Deal Type : Acquisition